3/20
09:28 pm
pfe
Pfizer Prostate Cancer Data Adds Context To Valuation And Pipeline Outlook [Yahoo! Finance]
Neutral
Report
Pfizer Prostate Cancer Data Adds Context To Valuation And Pipeline Outlook [Yahoo! Finance]
3/20
04:30 pm
pfe
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
Neutral
Report
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
3/19
08:10 pm
pfe
Pfizer aims for wider use of PARP drug in prostate cancer with new data [Yahoo! Finance]
Low
Report
Pfizer aims for wider use of PARP drug in prostate cancer with new data [Yahoo! Finance]
3/19
07:31 am
pfe
The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients [Fortune]
Low
Report
The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients [Fortune]
3/19
06:45 am
pfe
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Low
Report
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
3/18
08:06 pm
pfe
PFE's Atirmociclib 2L Breast Cancer Study Hits Goal, Aid Pipeline Push [Yahoo! Finance]
Low
Report
PFE's Atirmociclib 2L Breast Cancer Study Hits Goal, Aid Pipeline Push [Yahoo! Finance]
3/18
09:50 am
pfe
Contraceptives Drugs Market Size to Reach USD 46.24 Billion by 2035; Rising Awareness of Family Planning Driving Market Growth – SNS Insider [Yahoo! Finance]
Low
Report
Contraceptives Drugs Market Size to Reach USD 46.24 Billion by 2035; Rising Awareness of Family Planning Driving Market Growth – SNS Insider [Yahoo! Finance]
3/18
09:06 am
pfe
Pfizer: I'm Still Expecting A Massive Rebound [Seeking Alpha]
Low
Report
Pfizer: I'm Still Expecting A Massive Rebound [Seeking Alpha]
3/17
06:22 pm
pfe
Jim Cramer Notes Pfizer (PFE) Has “Got a Lot of Stuff in the Pipeline” [Yahoo! Finance]
Low
Report
Jim Cramer Notes Pfizer (PFE) Has “Got a Lot of Stuff in the Pipeline” [Yahoo! Finance]
3/17
04:17 pm
pfe
Pfizer's Ibrance successor moves forward with new study data [Yahoo! Finance]
Low
Report
Pfizer's Ibrance successor moves forward with new study data [Yahoo! Finance]
3/17
03:11 pm
pfe
Pfizer Reports Positive Mid-Stage Breast Cancer Trial Results [Yahoo! Finance]
Low
Report
Pfizer Reports Positive Mid-Stage Breast Cancer Trial Results [Yahoo! Finance]
3/17
01:11 pm
pfe
Pfizer (PFE) was given a new $27.00 price target by Morgan Stanley. They now have a "positive" rating on the stock.
Low
Report
Pfizer (PFE) was given a new $27.00 price target by Morgan Stanley. They now have a "positive" rating on the stock.
3/17
12:30 pm
pfe
Pfizer (PFE) had its price target raised by HSBC Holdings plc from $29.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
Pfizer (PFE) had its price target raised by HSBC Holdings plc from $29.00 to $32.00. They now have a "buy" rating on the stock.
3/17
11:28 am
pfe
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
Low
Report
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
3/17
09:58 am
pfe
CSPi Enhances Board of Director Capabilities with Addition of Cybersecurity Expert [Yahoo! Finance]
Low
Report
CSPi Enhances Board of Director Capabilities with Addition of Cybersecurity Expert [Yahoo! Finance]
3/17
08:02 am
pfe
VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors [Yahoo! Finance]
Low
Report
VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors [Yahoo! Finance]
3/17
06:58 am
pfe
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
3/17
06:45 am
pfe
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
Medium
Report
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
3/17
01:41 am
pfe
Should You Avoid Pfizer? Here's the Key Risk to Watch [Yahoo! Finance]
Medium
Report
Should You Avoid Pfizer? Here's the Key Risk to Watch [Yahoo! Finance]
3/16
03:55 pm
pfe
Federal judge blocks RFK Jr.'s efforts to reshape childhood vaccine policy [CNBC]
Low
Report
Federal judge blocks RFK Jr.'s efforts to reshape childhood vaccine policy [CNBC]
3/16
08:43 am
pfe
GSK's RSV jab secures FDA label expansion to larger adult population [Yahoo! Finance]
Low
Report
GSK's RSV jab secures FDA label expansion to larger adult population [Yahoo! Finance]
3/16
12:52 am
pfe
Pfizer Trials Highlight Effort To Broaden Future Revenue And Defend Franchises [Yahoo! Finance]
Low
Report
Pfizer Trials Highlight Effort To Broaden Future Revenue And Defend Franchises [Yahoo! Finance]
3/15
08:49 pm
pfe
Is Pfizer Inc. (PFE) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is Pfizer Inc. (PFE) A Good Stock To Buy Now? [Yahoo! Finance]
3/15
05:59 pm
pfe
Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks? [Yahoo! Finance]
Low
Report
Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks? [Yahoo! Finance]
3/13
05:03 pm
pfe
Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation [Seeking Alpha]
Low
Report
Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation [Seeking Alpha]